- Corporate Officers - L
- Lowe Christopher P.
Insider Trading History of Lowe Christopher P.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lowe Christopher P. since 2010.
This trader's CIK number is 1376260.
At the time of last reporting, Lowe Christopher P. was the Director of Vincerx Pharma, Inc.. (stock ticker symbol VINC).
Also see all insider trading activities at Vincerx Pharma, Inc..
Note that in the past
LOWE CHRISTOPHER P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cortexyme, Inc. (CRTX) by Lowe Christopher P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CRTX | 0 | $0 | 26,963 | $2,608,555 | 86,963 | $455,080 |
Yearly summary of insider trading at Hansen Medical Inc (HNSN) by Lowe Christopher P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | HNSN | 0 | $0 | 0 | $0 | 100,000 | $0 |
| 2014 | HNSN | 20,000 | $28,900 | 0 | $0 | 0 | $0 |
| 2013 | HNSN | 12,500 | $19,000 | 0 | $0 | 0 | $0 |
| 2010 | HNSN | 10,000 | $26,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anthera Pharmaceuticals Inc (ANTH) by Lowe Christopher P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | ANTH | 0 | $0 | 15,000 | $114,900 | 0 | $0 |
| 2011 | ANTH | 0 | $0 | 39,237 | $274,451 | 30,000 | $29,900 |
| 2010 | ANTH | 5,000 | $20,900 | 0 | $0 | 9,637 | $1,927 |
Yearly summary of insider trading at Vincerx Pharma, Inc. (VINC) by Lowe Christopher P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | VINC | 30,000 | $49,444 | 0 | $0 | 0 | $0 |
| 2021 | VINC | 10,000 | $126,152 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Lowe Christopher P.:
1. Cortexyme, Inc. (CRTX)
2. Hansen Medical Inc (HNSN)
3. Anthera Pharmaceuticals Inc (ANTH)
4. Vincerx Pharma, Inc. (VINC)
Table 1. Insider trading of Cortexyme, Inc. (CRTX) by Lowe Christopher P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-16 | CRTX | Option Ex | 30,000 | 2.23 | 66,900 |
| 2021-10-05 | CRTX | Sale | 4,963 | 98.50 | 488,855 |
| 2021-10-05 | CRTX | Option Ex | 4,963 | 54.85 | 272,220 |
| 2021-08-16 | CRTX | Sale | 22,000 | 96.35 | 2,119,700 |
| 2021-08-17 | CRTX | Option Ex | 30,000 | 2.23 | 66,900 |
| 2021-08-16 | CRTX | Option Ex | 22,000 | 2.23 | 49,060 |
Table 2. Insider trading of Hansen Medical Inc (HNSN) by Lowe Christopher P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-07-27 | HNSN | Option Ex | 100,000 | .00 | 0 |
| 2014-05-20 | HNSN | Buy | 20,000 | 1.45 | 28,900 |
| 2013-05-13 | HNSN | Buy | 12,500 | 1.52 | 19,000 |
| 2010-04-30 | HNSN | Buy | 10,000 | 2.66 | 26,600 |
Table 3. Insider trading of Anthera Pharmaceuticals Inc (ANTH) by Lowe Christopher P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-02-01 | ANTH | Sale | 15,000 | 7.66 | 114,900 |
| 2011-11-03 | ANTH | Sale | 15,000 | 6.88 | 103,230 |
| 2011-10-25 | ANTH | Sale | 4,637 | 7.07 | 32,783 |
| 2011-08-08 | ANTH | Option Ex | 10,000 | 1.34 | 13,400 |
| 2011-08-03 | ANTH | Sale | 14,600 | 6.88 | 100,433 |
| 2011-08-02 | ANTH | Sale | 5,000 | 7.60 | 38,005 |
| 2011-06-21 | ANTH | Option Ex | 20,000 | .82 | 16,500 |
| 2010-09-24 | ANTH | Buy | 5,000 | 4.18 | 20,900 |
| 2010-03-31 | ANTH | Option Ex | 9,637 | .20 | 1,927 |
Table 4. Insider trading of Vincerx Pharma, Inc. (VINC) by Lowe Christopher P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-08-24 | VINC | Buy | 18,400 | 1.65 | 30,304 |
| 2022-08-25 | VINC | Buy | 11,600 | 1.65 | 19,140 |
| 2021-06-29 | VINC | Buy | 6,400 | 12.59 | 80,576 |
| 2021-06-30 | VINC | Buy | 3,600 | 12.66 | 45,576 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lowe Christopher P.
(Director of Vincerx Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.